As of 2025-03-17, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (28.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.79 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -468.5%.
The range of the Relative Valuation is (17.89) - (41.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 26.4x | 16.5x |
| Forward P/E multiples | 9.3x - 23.0x | 15.4x |
| Fair Price | (17.89) - (41.47) | (28.71) |
| Upside | -329.7% - -632.3% | -468.5% |
| Date | P/E |
| 2025-03-04 | -4.26 |
| 2025-03-03 | -4.24 |
| 2025-02-28 | -4.46 |
| 2025-02-27 | -4.36 |
| 2025-02-26 | -4.61 |
| 2025-02-25 | -4.49 |
| 2025-02-24 | -4.20 |
| 2025-02-21 | -4.27 |
| 2025-02-20 | -4.15 |
| 2025-02-19 | -4.41 |
| 2025-02-18 | -4.36 |
| 2025-02-14 | -4.64 |
| 2025-02-13 | -4.59 |
| 2025-02-12 | -5.25 |
| 2025-02-11 | -5.47 |
| 2025-02-10 | -6.24 |
| 2025-02-07 | -6.81 |
| 2025-02-06 | -6.97 |
| 2025-02-05 | -6.88 |
| 2025-02-04 | -5.97 |
| 2025-02-03 | -5.64 |
| 2025-01-31 | -5.79 |
| 2025-01-30 | -5.98 |
| 2025-01-29 | -6.19 |
| 2025-01-28 | -6.49 |
| 2025-01-27 | -6.02 |
| 2025-01-24 | -5.74 |
| 2025-01-23 | -5.74 |
| 2025-01-22 | -5.48 |
| 2025-01-21 | -5.56 |
| 2025-01-17 | -5.32 |
| 2025-01-16 | -5.58 |
| 2025-01-15 | -6.04 |
| 2025-01-14 | -5.51 |
| 2025-01-13 | -4.78 |
| 2025-01-10 | -4.42 |
| 2025-01-08 | -4.72 |
| 2025-01-07 | -5.12 |
| 2025-01-06 | -4.62 |
| 2025-01-03 | -4.75 |
| 2025-01-02 | -4.59 |
| 2024-12-31 | -4.48 |
| 2024-12-30 | -4.54 |
| 2024-12-27 | -4.58 |
| 2024-12-26 | -4.64 |
| 2024-12-24 | -4.55 |
| 2024-12-23 | -4.63 |
| 2024-12-20 | -4.56 |
| 2024-12-19 | -4.27 |
| 2024-12-18 | -4.27 |